藥學院

Medicine & Life Sciences

1. Taiwan 100%
2. Apoptosis 42%
3. Neoplasms 41%
4. Proteins 33%
5. Stroke 30%
6. In Vitro Techniques 30%
7. Colorectal Neoplasms 28%
8. Cohort Studies 26%
9. Lipopolysaccharides 26%
10. Population 26%
11. Histone Deacetylase Inhibitors 25%
12. Inhibitory Concentration 50 25%
13. Arsenic 24%
14. Therapeutics 24%
15. Antioxidants 23%
16. Genes 23%
17. Growth 23%
18. Anti-Inflammatory Agents 20%
19. Cyclooxygenase 2 20%
20. Nitric Oxide 19%
21. Phosphorylation 19%
22. Cell Line 19%
23. Hepatocellular Carcinoma 19%
24. Macrophages 18%
25. Breast Neoplasms 18%
26. Chronic Renal Insufficiency 18%
27. Confidence Intervals 18%
28. Reactive Oxygen Species 17%
29. Kidney 17%
30. Pharmaceutical Preparations 17%
31. Nitric Oxide Synthase Type II 16%
32. Lung Neoplasms 16%
33. Gene Expression 16%
34. Autophagy 16%
35. Cell Proliferation 15%
36. Down-Regulation 15%
37. Traumatic Brain Injury 15%
38. Inflammation 15%
39. Cell Movement 14%
40. Colonic Neoplasms 14%
41. Up-Regulation 13%
42. Wounds and Injuries 13%
43. Water 13%
44. Endothelial Cells 13%
45. Histone Deacetylases 13%
46. Cell Death 13%
47. Caspase 3 13%
48. Non-Small Cell Lung Carcinoma 13%
49. Serum 12%
50. Pharmacokinetics 12%
51. Biomarkers 12%
52. Lung 12%
53. Mortality 12%
54. Oxidative Stress 12%
55. Blood Platelets 12%
56. Alzheimer Disease 12%
57. Neoplasm Metastasis 12%
58. Phosphotransferases 12%
59. Antineoplastic Agents 11%
60. High Pressure Liquid Chromatography 11%
61. Heme Oxygenase-1 11%
62. Liver 11%
63. Nanoparticles 11%
64. Messenger RNA 10%
65. Odds Ratio 10%
66. Heterografts 10%
67. Antrodia 10%
68. Acids 10%
69. Databases 10%
70. Protein Kinase C 10%
71. Smooth Muscle Myocytes 10%
72. Chronic Obstructive Pulmonary Disease 10%
73. Dementia 10%
74. Cytokines 10%
75. Meta-Analysis 10%
76. Glioblastoma 10%
77. Fibroblasts 10%
78. MicroRNAs 10%
79. Chinese Traditional Medicine 10%
80. Resveratrol 10%
81. Ipomoea batatas 9%
82. Flavonoids 9%
83. National Health Programs 9%
84. Glucose 9%
85. Tubulin 9%
86. p38 Mitogen-Activated Protein Kinases 9%
87. Matrix Metalloproteinase 9 9%
88. Extracellular Signal-Regulated MAP Kinases 9%
89. Western Blotting 9%
90. Matrix Metalloproteinases 9%
91. Mucocutaneous Lymph Node Syndrome 9%
92. Ethanol 9%
93. Hydroxyl Radical 9%
94. Transcription Factor AP-1 9%
95. Peroxisome Proliferator-Activated Receptors 9%
96. Renal Dialysis 9%
97. Enzymes 9%
98. ErbB Receptors 8%
99. Quercetin 8%

Chemical Compounds

1. Protein 46%
2. Drug 23%
3. Antioxidant Agent 22%
4. Antiinflammatory 19%
5. Histone 18%
6. Nitric Oxide 17%
7. Antiproliferative 15%
8. Apoptotic 15%
9. Cell Death 14%
10. Plasma 14%
11. Antitumor 13%
12. Reactive Oxygen Metabolite 13%
13. Lipopolysaccharide 13%
14. Antineoplastic Agent 12%
15. Application 10%
16. Marker 10%
17. Flavonoid 9%
18. Metabolite 9%
19. Pharmacokinetics 9%
20. Oxidative Stress 9%
21. Cell Viability 9%
22. Dose 9%
23. Protective 8%
24. Acid 8%
25. Genetic Polymorphism 8%
26. Biological Marker 8%
27. Disorder 8%
28. Growth Factor 8%
29. Leaf Like Crystal 8%
30. Collagen 8%
31. Glucose 8%
32. Quercetin 8%
33. Bioavailability 7%
34. 50 Percent Growth Inhibition 7%
35. Bioactivity 7%
36. Pharmacological Metabolism 7%
37. Metabolic 7%
38. Aristolochic Acid 7%
39. Air Pollution 6%
40. Glycoside 6%
41. Neuroprotective 6%
42. Glutathione 6%
43. Resistance 6%
44. Western Blotting 6%
45. Flow 6%
46. Hydroxamic Acid 6%
47. Nanoparticle 6%
48. Weight 6%
49. Resveratrol 6%
50. Blood Pressure 5%
51. Free Radical 5%
52. High-Pressure Liquid Chromatography 5%
53. Hydrogel 5%
54. Percutaneous 5%
55. Modification 5%
56. Lipid 5%
57. Superoxide 5%
58. Composite Material 5%
59. Surface 5%
60. Implant 5%
61. Ethanol 5%
62. Cleavage 5%
63. Peptide 5%
64. Calcium(0) 5%
65. Amount 5%
66. Lignan 5%
67. Time 5%
68. Baicalein 5%
69. Mutation 5%
70. Heme 5%
71. Food 5%
72. MicroRNA 5%